
|Articles|October 4, 2017
Lash Group Launches New Technology, Fusion
Advertisement
Lash Group-a part of AmerisourceBergen-announced the launch of its new patient support technology ecosystem, Fusion. Fusion is designed to combine technologies with workflows that are customized for patient support services. The technology has a proprietary data model for a personalized experience for patients, providers, and manufacturers.
Fusion was developed in collaboration with various technology partnerships and is designed to accelerate speed to therapy, improve patient and provider engagement, and generate actionable insights.
To learn more about Fusion, visit
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Economics of the 340B Drug Pricing Program: Strategic Imperatives for the Life Sciences Industry in 2026
2
Pharmaceutical Executive Daily: FDA Pilot Targets Faster Early-Stage Drug Trial Starts
3
How 3D Printing Speeds Up Drug Production
4
FDA Pilot Targets Faster Early-Stage Drug Trial Starts
5



